BioSpace News Archive

Lonza will establish Centers of Excellence for Cell and Gene Therapy to support and accelerate the growth of this priority area for the company.

TC BioPharm has announced it is opening of a new office in Japan to continue expansion of its Asian operations.

In connection with the Offering, the Issuer expects to grant the initial purchasers of the Notes a 30-day option to purchase up to an additional $18,750,000 principal amount of Notes.

In this role, Mr. Conway will be responsible for the integration of Cantel’s acquisitions along with his current role of leading the business systems function.

In this role, Alison will be responsible for shaping and delivering an integrated global commercial strategy to make bluebird’s gene therapies broadly accessible to patients.

The Mobile Insulin Dosing System has been cleared by the FDA for the titration of long-acting insulin for people with type 2 diabetes.

Simplify Medical today announced completion of enrollment in its U.S. IDE trial studying the Simplify Disc used for one-level cervical implantation of the device between C3 to C7 compared with a historical control group.

Aimmune today announced the expansion of its Scientific Advisory Board with the appointments of George du Toit, M.B., B.Ch., a Professor of Paediatric Allergy at King’s College London, Guy’s and St. Thomas’ NHS Foundation Trust, and Wayne G. Shreffler, M.D., Ph.D., Chief of Pediatric Allergy and Immunology and Director of the Food Allergy Center at Massachusetts General Hospital and Associate Professor of Pediatrics at Harvard Medical School.

Vertex Pharmaceuticals today announced positive results of a Phase 2 study of the NaV1.8 inhibitor VX-150 in patients with acute pain following bunionectomy surgery.

Novartis receives funding from Bill & Melinda Gates Foundation for further development of Novartis drug candidate KDU731 for the treatment of cryptosporidiosis.